Bio-Techne Corporation today announced that Advanced Cell Diagnostics (ACD), part of Bio-Techne's Spatial Biology Division, has published more than 10,000 peer-reviewed publications addressing the use and application of RNAscope. .™ ISH technology. Over 50% of these publications have been released in the past three years, with growing global customer awareness and expanding market adoption solidifying ACD's leadership in spatial biology applications. I am.
As a pioneer in spatial biology, Bio-Techne's broad portfolio of over 50,000 unique RNAscopes™ ISH probes spanning over 400 species enable biopharmaceutical and academic customers to uncover breakthrough biological discoveries, accelerate the development of next-generation therapeutics, and deliver life-changing diagnostics can. RNAscope represents the industry's most referenced spatial biology technology for RNA biomarkers™ Delivers best-in-class single molecule sensitivity with unparalleled specificity at subcellular resolution. This groundbreaking portfolio of 10,000 scientific publications includes applications in cancer and neuroscience, as well as additional research areas such as immunology, infectious diseases, cell and gene therapy, and regenerative medicine. Masu.
“We are thrilled to celebrate the achievement of over 10,000 publications mentioning RNAscope.™ ISH Technology” Matt McManus, President of Bio-Techne's Diagnostics and Genomics Division, said: “We are honored by the trust the scientific community has placed in RNAscope.”™ Uncover new spatial insights and enable important breakthroughs across a wide range of diseases. ”
